Sonoma PharmaceuticalsSNOA
13F holders, Q3 2024 (September 30)14holders +13
5new positions
1sold out
$3.07avg. 13F price*
At the end of Q3 2024, 14 institutions reported holding Sonoma Pharmaceuticals Inc. (SNOA) in their 13F filings, up 13 from Q2 2024. 5 opened new positions and 1 sold out. The largest holders were UBS Group AG ($39K), Ground Swell Capital, LLC ($32K) and Tower Research Capital LLC (TRC) ($13K).
- Company
- Sonoma Pharmaceuticals Inc.
- CUSIP
- 83558L303
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $33K |
| Exits | 1 | $1 |
All 13F filers, Q2 2024 → Q3 2024: 26,660 shares bought and 11 shares sold, net +26,649 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| UBS Group AG | 0.00% | Add +2113.7% | 12,730 | $39K |
| Ground Swell Capital, LLC | 0.05% | New | 10,400 | $32K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +937.9% | 4,141 | $13K |
| Citigroup Inc. | 0.00% | New | 180 | $553 |
| JPMorgan Chase & Co. | 0.00% | New | 138 | $424 |
| BlackRock, Inc. | 0.00% | — | 113 | $347 |
| Osaic Holdings, Inc. | 0.00% | Add +179.8% | 27 | $82 |
| US Bancorp \de | 0.00% | Add +3.6% | 25 | $77 |
| Morgan Stanley | 0.00% | Reduce -3.6% | 4 | $12 |
| Allworth Financial LP | 0.00% | Reduce -4.4% | 3 | $10 |
| Bank of America Corp. | 0.00% | Reduce -63.9% | 3 | $9 |
| Wells Fargo & Company | 0.00% | Reduce -37.2% | 1 | $3 |
| Danske Bank A/S | 0.00% | New | 1 | $3 |
| Royal Bank of Canada | 0.00% | New | 26 | $0 |
"% of holder's portfolio" is SNOA's weight in each manager's 13F, not the share of Sonoma Pharmaceuticals Inc. the manager owns.